Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

Brain and Behavior is a premier open-access journal published by WILEY, dedicated to advancing the field of Behavioral Neuroscience. With its ISSN 2162-3279, the journal has established itself as a vital resource for researchers, professionals, and students alike, fostering the dissemination of cutting-edge research since its inception in 2011. Renowned for its rigorous peer-review process, it enjoys a commendable Q2 ranking within the field, reflecting its impactful contributions and relevance in the scientific community. The journal not only emphasizes innovative studies that bridge behavioral science and neuroscience but also serves as a platform for diverse methodologies and interdisciplinary approaches. Accessible [open access](https://onlinelibrary.wiley.com/journal/21623279), Brain and Behavior invites submissions that explore the neural mechanisms underlying behavior, aiming to engage a global audience eager to expand the boundaries of knowledge in this dynamic field. Positioned in the heart of the United States, at 111 River St, Hoboken, NJ, it is strategically placed to collaborate with leading institutions and researchers worldwide.

Neuropsychiatria i Neuropsychologia is a pivotal journal dedicated to the exploration of behavioral neuroscience, neuropsychology, and psychiatry, published by TERMEDIA PUBLISHING HOUSE LTD in Poland. This journal, with an ISSN of 1896-6764, has been a significant contribution to the scientific community since its inception in 2009 and continues to converge its findings until 2024. While it operates under a traditional access model, its commitment to disseminating research in these critical fields is unwavering. The journal currently holds a Q4 classification in multiple categories including Behavioral Neuroscience and Neuropsychology, reflecting its growing influence in the landscape of mental health studies. With Scopus rankings displaying a percentile standing in the bottom quartile, Neuropsychiatria i Neuropsychologia presents an opportunity for authors and researchers to contribute and engage with emerging findings in psychiatry and behavioral science. By fostering scholarly communication and collaboration, this journal serves as a valuable resource for researchers, professionals, and students seeking to advance their understanding and knowledge within these vital areas of study.

Journal of Behavioral and Cognitive Therapy, published by ELSEVIER, is an esteemed academic journal dedicated to advancing the fields of clinical psychology, neuropsychology, and psychiatry through rigorous research and innovative practices. With an ISSN of 2589-9791 and Q2 rankings in both Clinical Psychology and Neuropsychology as of 2023, it demonstrates a strong commitment to fostering high-quality, impactful scholarship. Holding a Scopus Rank of 129 among 311 in Clinical Psychology, this journal serves as a significant platform for researchers and practitioners to disseminate their findings and engage in vital discussions surrounding behavioral and cognitive therapies. The journal's scope encompasses an array of topics pertinent to mental health, providing valuable insights that empower professionals and students alike. Although not Open Access, articles published within this journal have the potential to reach a diverse audience across the globe, enhancing collaboration and knowledge exchange in the critical arena of mental health. Located in France, the Journal of Behavioral and Cognitive Therapy continues to contribute to the global discourse on evidence-based practices and therapeutic innovations.

BEHAVIOURAL BRAIN RESEARCH, published by Elsevier, is a leading scholarly journal that has been at the forefront of research in Behavioral Neuroscience since its inception in 1980. With an ISSN of 0166-4328 and an e-ISSN of 1872-7549, this journal caters to a global audience of researchers and professionals keen on exploring the intricate relationships between behavior and neural processes. As of 2023, it holds an impressive Q2 ranking within its category, showcasing its significant impact with a Scopus rank of #28 out of 88 in the field, placing it in the 68th percentile. While the journal does not offer open access, it remains accessible through institutional subscriptions, ensuring that its high-quality research is disseminated effectively. The journal's commitment to advancing knowledge in behavioral neuroscience makes it an indispensable resource for those looking to delve deep into the complexities of brain-behavior interactions and foster innovative approaches in both research and clinical applications.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.

BIPOLAR DISORDERS, published by Wiley, is a leading international journal dedicated to advancing the understanding and treatment of bipolar disorders. Since its establishment in 1999, the journal has become a vital resource in the fields of Biological Psychiatry and Psychiatry and Mental Health, currently ranked in the Q2 category for Biological Psychiatry and Q1 for Psychiatry and Mental Health as of 2023. With impressive Scopus rankings, it stands at 75th out of 567 in Psychiatry and Mental Health and 11th out of 51 in Biological Psychiatry, reflecting its influential role in shaping mental health research. The journal not only focuses on empirical studies, reviews, and clinical reports but also encourages innovative methodological advancements in understanding bipolar disorders. Although it does not offer Open Access, its extensive coverage from 1999 to 2024 ensures that practitioners, researchers, and students have access to a wealth of knowledge critical for the development of effective therapeutic interventions. For those engaging with cutting-edge research in psychiatric care, BIPOLAR DISORDERS serves as an essential platform for knowledge dissemination and academic discourse.

The International Journal of Clinical and Health Psychology, published by Elsevier Science Inc, stands at the forefront of psychological research, delivering high-quality insights since its inception in 2005. With an impressive impact factor, this Open Access journal has established itself as a pivotal platform for scholars in the field, particularly noted for its ranking of Q1 in Clinical Psychology and a commendable 95th percentile in Scopus rankings. The journal focuses on advancing the understanding of psychological principles in clinical and health contexts, making it an essential resource for researchers, practitioners, and students alike. As the scope includes a wide array of topics related to clinical psychology, it aims to foster innovative research and promote the translation of scientific findings into practical applications, thereby enhancing psychological well-being globally. Since transitioning to Open Access in 2013, it has further increased its reach and accessibility, ensuring that important research is available to a diverse audience.

Journal of Cognitive Enhancement, published by SpringerNature, is a premier academic platform dedicated to advancing knowledge in the fields of Cognitive Neuroscience, Behavioral Neuroscience, and Experimental Psychology. With an electric combination of rigorous research and innovative practice, this journal has established itself as an essential resource for researchers, professionals, and students interested in understanding the mechanisms behind cognitive enhancement and its implications for mental health and cognitive function. As of 2023, it is recognized in the Q2 and Q3 quartiles across several categories, demonstrating its solid impact in the academic community, particularly with an impressive Scopus ranking of #27/76 in Neuropsychology and Physiological Psychology. Operating in a competitive landscape, the Journal of Cognitive Enhancement fosters open dialogue and collaboration through valuable contributions to cognitive research, facilitating insights that are crucial for practical applications in clinical and educational settings. While specific open access options are currently not defined, we encourage all interested scholars to explore the rich database of published works dating from 2017 to 2024, contributing to this dynamic field of study.

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.